lean mass) and impacts on cardiometabolic health, NAFLD, and physical function
Tirzepatide is currently being investigated in the SURMOUNT cardiovascular outcomes trial of adults with obesity
For patients currently in compounded GLP-1 programs, the transition would likely involve one of several options: switching to an FDA-approved branded medication (at substantially higher cost), discussing alternative weight management approaches with a licensed provider, or exploring whether 503A patient-specific compounding applies to their individual clinical situation
Our Hillsboro location has also been awarded the PCPCH Health Equity Designation
When calories and protein are too low, the body may also lose lean mass
The same inflammation management principles apply to other GLP-1 medication side effects , making hydrocortisone a versatile addition to any injection supply kit